Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 288.3 Million USD | 1.27% |
| 2022 | 284.69 Million USD | 2130.79% |
| 2021 | -14.01 Million USD | 35.25% |
| 2020 | -21.65 Million USD | -17.65% |
| 2019 | -18.4 Million USD | 27.82% |
| 2018 | -25.49 Million USD | -85.8% |
| 2017 | -13.72 Million USD | -4.02% |
| 2016 | -13.19 Million USD | -28.29% |
| 2015 | -10.28 Million USD | -15.85% |
| 2014 | -8.87 Million USD | 40.53% |
| 2013 | -14.92 Million USD | 36.6% |
| 2012 | -23.54 Million USD | -67.95% |
| 2011 | -14.02 Million USD | -11.99% |
| 2010 | -12.51 Million USD | 45.16% |
| 2009 | -22.82 Million USD | 37.52% |
| 2008 | -36.54 Million USD | -230.56% |
| 2007 | -11.05 Million USD | 6.32% |
| 2006 | -11.8 Million USD | -124.33% |
| 2005 | -5.26 Million USD | 25.6% |
| 2004 | -7.07 Million USD | 31.29% |
| 2003 | -10.29 Million USD | -24.34% |
| 2002 | -8.27 Million USD | -30.25% |
| 2001 | -6.35 Million USD | -78.38% |
| 2000 | -3.56 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 328.73 Million USD | 14.02% |
| 2024 Q2 | 350.76 Million USD | 6.7% |
| 2023 Q4 | 288.3 Million USD | 14.51% |
| 2023 Q3 | 251.76 Million USD | 0.87% |
| 2023 Q2 | 249.58 Million USD | -5.3% |
| 2023 Q1 | 263.55 Million USD | -7.43% |
| 2023 FY | 288.3 Million USD | 1.27% |
| 2022 Q1 | 93.04 Million USD | 763.71% |
| 2022 Q2 | 239.88 Million USD | 157.82% |
| 2022 Q3 | 268.73 Million USD | 12.02% |
| 2022 Q4 | 284.69 Million USD | 5.94% |
| 2022 FY | 284.69 Million USD | 2130.79% |
| 2021 Q3 | -11.61 Million USD | 36.43% |
| 2021 FY | -14.01 Million USD | 35.25% |
| 2021 Q4 | -14.01 Million USD | -20.68% |
| 2021 Q1 | -6.39 Million USD | 70.45% |
| 2021 Q2 | -18.27 Million USD | -185.56% |
| 2020 Q2 | -18.72 Million USD | -152.28% |
| 2020 Q4 | -21.65 Million USD | -425.28% |
| 2020 Q1 | -7.42 Million USD | 59.68% |
| 2020 FY | -21.65 Million USD | -17.65% |
| 2020 Q3 | -4.12 Million USD | 77.98% |
| 2019 Q4 | -18.4 Million USD | -28.19% |
| 2019 Q3 | -14.35 Million USD | 22.41% |
| 2019 Q2 | -18.5 Million USD | -93.58% |
| 2019 Q1 | -9.55 Million USD | 62.51% |
| 2019 FY | -18.4 Million USD | 27.82% |
| 2018 Q1 | -10.32 Million USD | 24.75% |
| 2018 Q3 | -21.22 Million USD | -19.47% |
| 2018 Q4 | -25.49 Million USD | -20.13% |
| 2018 FY | -25.49 Million USD | -85.8% |
| 2018 Q2 | -17.76 Million USD | -72.04% |
| 2017 Q2 | -18.07 Million USD | -66.16% |
| 2017 Q4 | -13.72 Million USD | 3.89% |
| 2017 FY | -13.72 Million USD | -4.02% |
| 2017 Q1 | -10.87 Million USD | 17.55% |
| 2017 Q3 | -14.27 Million USD | 21.0% |
| 2016 Q2 | -6.83 Million USD | -18.67% |
| 2016 FY | -13.19 Million USD | -28.29% |
| 2016 Q4 | -13.19 Million USD | -23.55% |
| 2016 Q3 | -10.67 Million USD | -56.27% |
| 2016 Q1 | -5.75 Million USD | 44.01% |
| 2015 FY | -10.28 Million USD | -15.85% |
| 2015 Q1 | -12.66 Million USD | -42.66% |
| 2015 Q2 | -10.92 Million USD | 13.71% |
| 2015 Q3 | -9.51 Million USD | 12.91% |
| 2015 Q4 | -10.28 Million USD | -8.06% |
| 2014 Q2 | -9.76 Million USD | -2.28% |
| 2014 FY | -8.87 Million USD | 40.53% |
| 2014 Q4 | -8.87 Million USD | 14.22% |
| 2014 Q3 | -10.34 Million USD | -6.01% |
| 2014 Q1 | -9.54 Million USD | 36.07% |
| 2013 FY | -14.92 Million USD | 36.6% |
| 2013 Q1 | -15.82 Million USD | 28.91% |
| 2013 Q3 | -13.8 Million USD | -31.51% |
| 2013 Q2 | -10.49 Million USD | 33.65% |
| 2013 Q4 | -14.92 Million USD | -8.12% |
| 2012 Q1 | -12.78 Million USD | 8.79% |
| 2012 Q3 | -24.33 Million USD | -36.8% |
| 2012 FY | -23.54 Million USD | -67.95% |
| 2012 Q2 | -17.78 Million USD | -39.11% |
| 2012 Q4 | -22.25 Million USD | 8.53% |
| 2011 Q3 | -13.87 Million USD | 20.64% |
| 2011 Q4 | -14.02 Million USD | -1.05% |
| 2011 FY | -14.02 Million USD | -11.99% |
| 2011 Q1 | -13.16 Million USD | -5.15% |
| 2011 Q2 | -17.48 Million USD | -32.81% |
| 2010 FY | -12.51 Million USD | 45.16% |
| 2010 Q3 | -21.7 Million USD | 31.53% |
| 2010 Q4 | -12.51 Million USD | 42.32% |
| 2010 Q2 | -31.69 Million USD | -40.76% |
| 2010 Q1 | -22.51 Million USD | 1.36% |
| 2009 Q3 | -34.3 Million USD | 3.22% |
| 2009 Q4 | -22.82 Million USD | 33.45% |
| 2009 Q1 | -35.79 Million USD | 2.04% |
| 2009 Q2 | -35.44 Million USD | 0.97% |
| 2009 FY | -22.82 Million USD | 37.52% |
| 2008 FY | -36.54 Million USD | -230.56% |
| 2008 Q3 | -26.68 Million USD | -30.39% |
| 2008 Q4 | -36.54 Million USD | -36.94% |
| 2008 Q2 | -20.46 Million USD | 46.3% |
| 2008 Q1 | -38.11 Million USD | -244.76% |
| 2007 Q3 | -11.37 Million USD | -9.27% |
| 2007 Q4 | -11.05 Million USD | 2.83% |
| 2007 Q2 | -10.41 Million USD | 38.31% |
| 2007 Q1 | -16.87 Million USD | -43.02% |
| 2007 FY | -11.05 Million USD | 6.32% |
| 2006 FY | -11.8 Million USD | -124.33% |
| 2006 Q2 | -1.92 Million USD | 34.84% |
| 2006 Q4 | -11.8 Million USD | -285.87% |
| 2006 Q1 | -2.95 Million USD | 43.9% |
| 2006 Q3 | -3.05 Million USD | -59.02% |
| 2005 Q2 | -6.95 Million USD | 32.21% |
| 2005 Q4 | -5.26 Million USD | -11.25% |
| 2005 FY | -5.26 Million USD | 25.6% |
| 2005 Q1 | -10.26 Million USD | -45.15% |
| 2005 Q3 | -4.72 Million USD | 32.04% |
| 2004 Q2 | -52.65 Million USD | -379.61% |
| 2004 Q1 | -10.97 Million USD | -6.69% |
| 2004 Q3 | -55.91 Million USD | -6.19% |
| 2004 Q4 | -7.07 Million USD | 87.35% |
| 2004 FY | -7.07 Million USD | 31.29% |
| 2003 Q4 | -10.29 Million USD | 0.0% |
| 2003 FY | -10.29 Million USD | -24.34% |
| 2002 FY | -8.27 Million USD | -30.25% |
| 2001 FY | -6.35 Million USD | -78.38% |
| 2000 FY | -3.56 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -964.545% |
| BrainsWay Ltd. | -10.32 Million USD | 2893.605% |
| Cerus Corporation | 84.35 Million USD | -241.782% |
| Envoy Medical, Inc. | -3.81 Million USD | 7658.993% |
| electroCore, Inc. | -9.95 Million USD | 2996.032% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 5725.366% |
| IceCure Medical Ltd | -9.93 Million USD | 3002.154% |
| Inogen, Inc. | -103.56 Million USD | 378.365% |
| OrthoPediatrics Corp. | -9.26 Million USD | 3211.039% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 8018.154% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 2301.261% |
| MaxCyte, Inc. | -27.76 Million USD | 1138.432% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 5711.031% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 50172.338% |
| Orthofix Medical Inc. | 96.44 Million USD | -198.936% |
| PAVmed Inc | 29.08 Million USD | -891.199% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 1801.989% |
| RxSight, Inc. | -6.68 Million USD | 4415.868% |
| Sight Sciences, Inc. | -102.71 Million USD | 380.68% |
| SI-BONE, Inc. | 5.72 Million USD | -4939.329% |
| TELA Bio, Inc. | -3.94 Million USD | 7400.582% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -402.957% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -81803.409% |
| Acutus Medical, Inc. | 12.27 Million USD | -2247.911% |
| Talis Biomedical Corporation | -57.06 Million USD | 605.222% |
| Spectral AI, Inc. | -3.5 Million USD | 8334.79% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 700.287% |
| CVRx, Inc. | -59.95 Million USD | 580.853% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -14430.188% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -22465.095% |
| Bioventus Inc. | 372.51 Million USD | 22.607% |
| Venus Concept Inc. | 74.3 Million USD | -288.016% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 2931.467% |
| LivaNova PLC | 62.53 Million USD | -361.044% |
| 908 Devices Inc. | -115.09 Million USD | 350.487% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 10.105% |
| Nemaura Medical Inc. | 9.92 Million USD | -2804.781% |
| NeuroPace, Inc. | 54.33 Million USD | -430.578% |
| LENSAR, Inc. | -18.31 Million USD | 1674.377% |
| Apyx Medical Corporation | -5.15 Million USD | 5696.971% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -3736.327% |
| BioSig Technologies, Inc. | 262 Thousand USD | -109938.168% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 757.769% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 3234.036% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 79.485% |
| Axonics, Inc. | -77.19 Million USD | 473.475% |
| Outset Medical, Inc. | 67.67 Million USD | -325.981% |
| IRIDEX Corporation | -4.28 Million USD | 6823.414% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 261.95% |
| IRadimed Corporation | -47.71 Million USD | 704.16% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 9627.429% |
| INVO Bioscience, Inc. | 8.45 Million USD | -3311.375% |
| Telesis Bio, Inc. | 32.63 Million USD | -783.407% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 11622.174% |
| Varex Imaging Corporation | 316.9 Million USD | 9.025% |
| Quipt Home Medical Corp. | 81.73 Million USD | -252.727% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 10463.048% |
| Pulmonx Corporation | -42.36 Million USD | 780.595% |
| Dynatronics Corporation | 6.2 Million USD | -4546.977% |
| Modular Medical, Inc. | -8.04 Million USD | 3684.929% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 6809.332% |
| Semler Scientific, Inc. | -57.13 Million USD | 604.639% |
| InMode Ltd. | -135.39 Million USD | 312.934% |
| Bruker Corporation | 891.3 Million USD | 67.654% |
| Cytosorbents Corporation | 4.18 Million USD | -6793.806% |
| DexCom, Inc. | 2.02 Billion USD | 85.782% |
| Align Technology, Inc. | -840.47 Million USD | 134.302% |
| Viveve Medical, Inc. | -13.81 Million USD | 2187.164% |
| ZimVie Inc. | 450.41 Million USD | 35.993% |
| Movano Inc. | -5.86 Million USD | 5014.763% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 314.42% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 50172.338% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -14430.188% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 19.198% |
| Profound Medical Corp. | -18.17 Million USD | 1685.938% |
| Insulet Corporation | 798.1 Million USD | 63.877% |
| enVVeno Medical Corporation | -2.21 Million USD | 13098.197% |
| Surmodics, Inc. | -12.01 Million USD | 2499.7% |
| iCAD, Inc. | -21.2 Million USD | 1459.329% |
| Nuwellis, Inc. | -2.81 Million USD | 10327.031% |
| Biotricity, Inc. | 23.09 Million USD | -1148.445% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -207.845% |
| Aethlon Medical, Inc. | -4.5 Million USD | 6504.301% |
| InspireMD, Inc. | -8.04 Million USD | 3683.592% |
| PAVmed Inc. | 29.08 Million USD | -891.199% |
| BIOLASE, Inc. | 11.34 Million USD | -2441.432% |
| Beyond Air, Inc. | 6.22 Million USD | -4528.351% |
| FONAR Corporation | -14.66 Million USD | 2065.862% |
| AxoGen, Inc. | 32.26 Million USD | -793.51% |
| Vivani Medical, Inc. | 42 Thousand USD | -686328.571% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 2805.01% |
| Inari Medical, Inc. | -7.16 Million USD | 4125.973% |
| UFP Technologies, Inc. | 40.77 Million USD | -607.068% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -9295.09% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 6142.366% |
| Tenon Medical, Inc. | -1.25 Million USD | 23072.112% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 3890.429% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 2517.344% |
| AdaptHealth Corp. | 2.21 Billion USD | 86.999% |
| Sintx Technologies, Inc. | 905 Thousand USD | -31756.354% |
| NanoVibronix, Inc. | -3.27 Million USD | 8894.997% |
| Quanterix Corporation | -132.95 Million USD | 316.835% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 10463.048% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 1389.068% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 61.75% |
| TransMedics Group, Inc. | 121.13 Million USD | -138.001% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 1201.222% |
| NeuroMetrix, Inc. | -1.49 Million USD | 19435.108% |
| Hyperfine, Inc. | -75.61 Million USD | 481.253% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -89.436% |
| Biomerica, Inc. | -3.38 Million USD | 8616.987% |
| Bone Biologics Corporation | -3.02 Million USD | 9625.638% |
| AVITA Medical, Inc. | -26.23 Million USD | 1199.055% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 15782.021% |
| Silk Road Medical, Inc | 64.42 Million USD | -347.511% |